Depression and Suicide Clinical Trial
Official title:
Accelerated Intermittent Theta Burst Stimulation for Depressive Symptoms
This study evaluates an accelerated schedule of theta-burst stimulation for depressive symptoms in psychiatric inpatients. A small pilot study (n=22) will be carried out to demonstrate feasibility, using the FDA-approved stimulation site for depression treatment (L-DLPFC). Participants will be offered stimulation at the anterior cingulate cortex (ACC).
This study intends to investigate whether modifying stimulation parameters enables typical 6-8 week long rTMS protocols to be compressed to only five days. The influence of this accelerated protocol on the length of patient stay in the hospital will be investigated. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06009523 -
Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
|
N/A | |
Completed |
NCT02566980 -
Biological Triggers of Depression in Pregnancy
|
||
Completed |
NCT04266288 -
Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department
|
Phase 4 | |
Recruiting |
NCT05437588 -
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
|
N/A | |
Recruiting |
NCT04760652 -
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention
|
N/A | |
Active, not recruiting |
NCT05930912 -
Psychiatric Orders in Psychoanalytic Treatment of ASD
|
||
Not yet recruiting |
NCT06426342 -
Development and Feasibility of a Metaverse-based Blended Online Intervention to Prevent Employees' Depression
|
N/A | |
Recruiting |
NCT04572321 -
Youth Depression and Suicide Research Network
|